✦ LIBER ✦

Survival following combination chemotherapy in advanced high grade non-Hodgkin's lymphomas: Relation to proliferative activity of the lymphoma cells

✍ Scribed by Lars Brandt; Håkan Olsson

Book ID: 114790814
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 310 KB
Volume: 38
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1987.tb01441.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new approach to the treatment of advan

A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma — intensive two-phase chemotherapy

✍ Nicholas S. A. Stuart; George R. P. Blackledge; J. Anthony Child; John Fletcher; 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 625 KB

A total of 110 patients with high-grade non-Hodgkin's lymphoma (NHL) not previously treated by chemotherapy or by radiotherapy at more than one site of disease underwent a regimen comprising an intensive 6-week initial, induction phase using vincristine, adriamycin, methotrexate, and prednisolone (V

PO39 Long-term survival after histologic

PO39 Long-term survival after histologic transformation from high grade B cell non-Hodgkin's lymphoma to low grade follicular lymphoma and Hodgkin's disease in the same patient

✍ A. Tolosa; A. Escriva; J. Ros; A. Garcia; M. Fernandez; M.J. Sayas; R. Andreu; P 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 44 KB

A Randomized Controlled Trial Investigat

A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin’s Lymphoma: Japan Clinical Oncology Group Study 9002

✍ Tomohiro Kinoshita; Tomomitsu Hotta; Kensei Tobinai; Tohru Kobayashi; Naoki Ishi 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 253 KB

Excellent survival following two courses

Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB 96 international study

✍ Mary Gerrard; Mitchell S. Cairo; Claire Weston; Anne Auperin; Ross Pinkerton; An 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Oral combination chemotherapy in conjunc

Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: Evaluation of the role of G-CSF; Quality-of-life analysis and long-term follow-up

✍ Scot C. Remick; Nell Sedransk; Richard F. Haase; Christina G. Blanchard; Carm R. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB